NASDAQ:FBCG

Fidelity Blue Chip Growth Etf ETF News

etoro logo Buy FBCG
*Your capital is at risk
$59.97
-0.770 (-1.27%)
At Close: Jul 17, 2026

FBCG: Way Too Aggressive For Using Right Now

05:45am, Saturday, 19'th Jul 2025
FBCG's heavy tech and Mag7 exposure offers high-growth potential but increases idiosyncratic risk and volatility versus the S&P 500. Recent performance has shown strong momentum, but risk-adjusted ret

Fidelity Aims to Be a Top 3 Active ETF Provider

11:07am, Tuesday, 13'th May 2025
After a strong 2024, Fidelity ETFs gathered approximately $10 billion in the first four months of 2025. Demand for actively managed products has been a key driver as Fidelity leans further into the ET

FBCG: An Attractive ETF For Dip Buyers

12:58am, Monday, 28'th Apr 2025
Fidelity Blue Chip Growth ETF offers a prime buying opportunity due to its fundamental analysis and bottom-up stock picking approach, focusing on high-growth sectors. The current market selloff has cr
Despite the ETF industry's passive roots, active has stolen the show. Active ETF assets just topped the $1 trillion threshold, making up nearly 10% of the total ETF pie.
Retail investors do not need to worry about picking individual stocks to ensure steady returns.
Many investors favor blue chip stocks for their stability. This stability makes a blue chip ETF a familiar option during periods of market and economic stress.

Undercovered ETFs: Growth, Income, TIPS, Poland +

08:00am, Thursday, 20'th Feb 2025
The 'Undercovered' Dozen series highlights 12 lesser-known ETFs offering potential investment opportunities for investors. Kurtis Hemmerling shares a bearish take on iShares Russell Top 200 Growth ETF
Warren Buffett has outperformed the S&P 500 for many years, and he continues to deliver impressive gains for investors.
FBCG offers investors exposure to blue chip U.S. large cap growth equities. The fund's gross expense ratio of 0.60% is significantly higher than comparable index ETFs and somewhat higher than comparab
This article will provide an in-depth analysis of drugs being developed to combat cancer. Big Pharma is keenly interested in the global cancer therapeutics market, which is expected to exceed $400 bil

VIDEO: ETF of the Week: FBCG

01:02pm, Monday, 13'th Jan 2025
On this episode of “ETF of the Week” podcast, VettaFi's Head of Research Todd Rosenbluth joined Chuck Jaffe of Money Life to talk about the Fidelity Blue Chip Growth ETF (FBCG).  Chuck Jaffe: One
VettaFi's Head of Research Todd Rosenbluth discussed the Fidelity Blue Chip Growth ETF (FBCG) on this week's “ETF of the Week” podcast with Chuck Jaffe of “Money Life.” For more news, informa
Investors poured in 31.7 billion in capital to start 2025, with U.S. equity ETFs leading the way.

Blue-Chip ETF (FBCG) Hits New 52-Week High

10:16am, Tuesday, 07'th Jan 2025
For investors seeking momentum, Fidelity Blue Chip Growth ETF FBCG is probably on the radar. The fund just hit a 52-week high and has moved up 46.4% from its 52-week low of $32.91 per share.
With the end of the year on the horizon, investors often reflect on insights from the market's performance. Three ETFs from Fidelity Investments can offer some notable takeaways as they are likely to
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE